Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018

[1] Farolfi A(2019)Highlights from 2017: impactful topics published in the annals of nuclear medicine Eur J Nucl Med Mol Imaging 46 217-223

[2] Ghedini P(2017)Highlights of articles published in annals of nuclear medicine 2016 Eur J Nucl Med Mol Imaging 44 1928-1933

[3] Fanti S(2018)European research trends in nuclear medicine Ann Nucl Med 32 579-582

[4] Jadvar H(2017)Topics of nuclear medicine research in Europe Ann Nucl Med 31 571-574

[5] Inubushi M(1961)The History of Quantification in Medical Science Isis 52 215-237

[6] Tatsumi M(2018)Evolution of quantification in clinical nuclear medicine: a brief overview of salient uses and upcoming trends J Nucl Med Radiat Ther 09 375-494

[7] Yamamoto Y(2017)PET radiomics in NSCLC: state of the art and a proposal for harmonization of methodology Sci Rep 7 358-531

[8] Kato K(2019)Development of anatomically and lesion contrast-guided partial volume correction: new 3D formalisms and validation in phantom and clinical studies Ann Nucl Med 33 481-377

[9] Tsujikawa T(2018)Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients Ann Nucl Med 32 523-541

[10] Nishii R(2018)FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) Ann Nucl Med 32 372-694

[1] Farolfi A(2019)Highlights from 2017: impactful topics published in the annals of nuclear medicine Eur J Nucl Med Mol Imaging 46 217-223

[2] Ghedini P(2017)Highlights of articles published in annals of nuclear medicine 2016 Eur J Nucl Med Mol Imaging 44 1928-1933

[3] Fanti S(2018)European research trends in nuclear medicine Ann Nucl Med 32 579-582

[4] Jadvar H(2017)Topics of nuclear medicine research in Europe Ann Nucl Med 31 571-574

[5] Inubushi M(1961)The History of Quantification in Medical Science Isis 52 215-237

[6] Tatsumi M(2018)Evolution of quantification in clinical nuclear medicine: a brief overview of salient uses and upcoming trends J Nucl Med Radiat Ther 09 375-494

[7] Yamamoto Y(2017)PET radiomics in NSCLC: state of the art and a proposal for harmonization of methodology Sci Rep 7 358-531

[8] Kato K(2019)Development of anatomically and lesion contrast-guided partial volume correction: new 3D formalisms and validation in phantom and clinical studies Ann Nucl Med 33 481-377

[9] Tsujikawa T(2018)Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients Ann Nucl Med 32 523-541

[10] Nishii R(2018)FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) Ann Nucl Med 32 372-694